How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study ; volume:161 ; number:3 ; day:1 ; month:2 ; year:2023 ; pages:525-538 ; date:2.2023
Journal of neuro-oncology ; 161, Heft 3 (1.2.2023), 525-538, 2.2023
- Urheber
-
Perwein, Thomas
Giese, Barbara
Nussbaumer, Gunther
Bueren, André von
Buiren, Miriam van
Benesch, Martin
Kramm, Christof Maria
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11060-023-04241-6
- URN
-
urn:nbn:de:101:1-2410141129555.692472736068
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Perwein, Thomas
- Giese, Barbara
- Nussbaumer, Gunther
- Bueren, André von
- Buiren, Miriam van
- Benesch, Martin
- Kramm, Christof Maria
- SpringerLink (Online service)
Ähnliche Objekte (12)
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review
Multifocal high-grade glioma radiotherapy safety and efficacy
Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial
α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
HGG-16. Pediatric-type diffuse high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features [Abstract]
A prognostic neural epigenetic signature in high-grade glioma
A prognostic neural epigenetic signature in high-grade glioma
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review
Multifocal high-grade glioma radiotherapy safety and efficacy
Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial
α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
HGG-16. Pediatric-type diffuse high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features [Abstract]
A prognostic neural epigenetic signature in high-grade glioma
A prognostic neural epigenetic signature in high-grade glioma
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review
Multifocal high-grade glioma radiotherapy safety and efficacy
Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial
α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
HGG-16. Pediatric-type diffuse high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features [Abstract]
A prognostic neural epigenetic signature in high-grade glioma